Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Xylem Inc.XYL · Entity 430 | EVP & President, WSS | March 05, 2026 | March 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Xylem Inc.
Report date March 05, 2026 · Filed March 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 73,683 |
Reported balance
After 2026-03-05 transaction · row 1
1 source rowRow 1 · 2026-03-05 · Tax withholding · Disposed 234 · Balance 73,683 F1: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 5, 2025 (234) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 5, 2025 (234) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Evoqua Water Technologies Corp.
Report date May 24, 2023 · Filed May 26, 2023
Section 16 reporting ended · disclosed 2023-05-26. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2023-05-24 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-05-24 · Grant · Acquired 25,114 · Balance 155,703 F1: Represents performance share units ("PSUs") that became earned (at target award level) pursuant to the merger agreement among Xylem Inc., Fore Merger Sub, Inc. and the issuer, dated as of Jan. 22, 2023, upon effectiveness of the merger on May 24, 2023. Row 2 · 2023-05-24 · Disposition to issuer · Disposed 155,703 · Balance 0 F2: Disposed of pursuant to the merger agreement. Upon effectiveness of the merger, (i) each issued and outstanding share of issuer common stock was exchanged for 0.48 Xylem common shares, with cash paid in lieu of fractional shares, and (ii) unvested restricted stock units ("RSUs") and PSUs (at target award level) were converted into RSUs relating to Xylem common shares, by multiplying the number of shares of issuer common stock underlying the award and 0.48, rounded down to the nearest whole share. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $20.88 · Expires 2028-04-02 | Direct | 0 |
Reported balance
After 2023-05-24 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-05-24 · Disposition to issuer · Disposed 49,730 · Balance 0 F5: Pursuant to the merger agreement, the Xylem option exercise price is equal to the issuer option exercise price divided by 0.48, rounded up to the nearest whole cent. F3: This option is fully vested. F4: Pursuant to the merger agreement, outstanding options for issuer common stock were assumed by Xylem and converted into options for Xylem common shares, in an amount equal to the number of shares of issuer common stock underlying the options multiplied by 0.48, rounded down to the nearest whole share. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.67 · Expires 2029-02-14 | Direct | 0 |
Reported balance
After 2023-05-24 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2023-05-24 · Disposition to issuer · Disposed 19,280 · Balance 0 F5: Pursuant to the merger agreement, the Xylem option exercise price is equal to the issuer option exercise price divided by 0.48, rounded up to the nearest whole cent. F3: This option is fully vested. F4: Pursuant to the merger agreement, outstanding options for issuer common stock were assumed by Xylem and converted into options for Xylem common shares, in an amount equal to the number of shares of issuer common stock underlying the options multiplied by 0.48, rounded down to the nearest whole share. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $23.63 · Expires 2030-02-14 | Direct | 0 |
Reported balance
After 2023-05-24 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2023-05-24 · Disposition to issuer · Disposed 45,417 · Balance 0 F5: Pursuant to the merger agreement, the Xylem option exercise price is equal to the issuer option exercise price divided by 0.48, rounded up to the nearest whole cent. F4: Pursuant to the merger agreement, outstanding options for issuer common stock were assumed by Xylem and converted into options for Xylem common shares, in an amount equal to the number of shares of issuer common stock underlying the options multiplied by 0.48, rounded down to the nearest whole share. F6: This option vests in four equal annual installments starting on Jan. 1, 2021. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $24.76 · Expires 2031-02-16 | Direct | 0 |
Reported balance
After 2023-05-24 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2023-05-24 · Disposition to issuer · Disposed 36,200 · Balance 0 F5: Pursuant to the merger agreement, the Xylem option exercise price is equal to the issuer option exercise price divided by 0.48, rounded up to the nearest whole cent. F4: Pursuant to the merger agreement, outstanding options for issuer common stock were assumed by Xylem and converted into options for Xylem common shares, in an amount equal to the number of shares of issuer common stock underlying the options multiplied by 0.48, rounded down to the nearest whole share. F7: This option vests in four equal installments starting on Feb. 16, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents performance share units ("PSUs") that became earned (at target award level) pursuant to the merger agreement among Xylem Inc., Fore Merger Sub, Inc. and the issuer, dated as of Jan. 22, 2023, upon effectiveness of the merger on May 24, 2023.
F2: Disposed of pursuant to the merger agreement. Upon effectiveness of the merger, (i) each issued and outstanding share of issuer common stock was exchanged for 0.48 Xylem common shares, with cash paid in lieu of fractional shares, and (ii) unvested restricted stock units ("RSUs") and PSUs (at target award level) were converted into RSUs relating to Xylem common shares, by multiplying the number of shares of issuer common stock underlying the award and 0.48, rounded down to the nearest whole share.
F3: This option is fully vested.
F4: Pursuant to the merger agreement, outstanding options for issuer common stock were assumed by Xylem and converted into options for Xylem common shares, in an amount equal to the number of shares of issuer common stock underlying the options multiplied by 0.48, rounded down to the nearest whole share.
F5: Pursuant to the merger agreement, the Xylem option exercise price is equal to the issuer option exercise price divided by 0.48, rounded up to the nearest whole cent.
F6: This option vests in four equal annual installments starting on Jan. 1, 2021.
F7: This option vests in four equal installments starting on Feb. 16, 2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 05, 2026 Filed Mar 6, 2026 21:17 UTC | Xylem Inc. XYL · Entity 430 | Tax withholdingCommon Stock | 234 | $126.19 | $29,528.46 |
DisclosureSEC source: 0001524472-26-000052 · form4.xml · nonDerivative · entry 1 Aulick Rodney · CIK 0001720147 · EVP & President, WSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,683 F1 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 5, 2025 (234) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:52 UTC | Xylem Inc. XYL · Entity 430 | GrantNon-Qualified Stock Options (Right to Buy) · Derivative | 5,739 | $128.98 Strike: $128.98 | $740,216.22 |
DisclosureSEC source: 0001524472-26-000035 · form4.xml · derivative · entry 3 Aulick Rodney · CIK 0001720147 · EVP & President, WSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,739 Underlying: Common Stock · 5,739 shares Expires 2036-03-02 F4 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028 and March 1, 2029. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:52 UTC | Xylem Inc. XYL · Entity 430 | Tax withholdingCommon Stock | 238 | $128.98 | $30,697.24 |
DisclosureSEC source: 0001524472-26-000035 · form4.xml · nonDerivative · entry 2 Aulick Rodney · CIK 0001720147 · EVP & President, WSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,917 F3 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2024 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:52 UTC | Xylem Inc. XYL · Entity 430 | GrantCommon Stock | 1,610 | $0.00 | $0.00 |
DisclosureSEC source: 0001524472-26-000035 · form4.xml · nonDerivative · entry 1 Aulick Rodney · CIK 0001720147 · EVP & President, WSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,155 F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 1, 2027, March 1, 2028 and March 1, 2029. F2 · balance_after: Includes additional shares due to dividend reinvestment. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:15 UTC | Xylem Inc. XYL · Entity 430 | Tax withholdingCommon Stock | 457 | $136.18 | $62,234.26 |
DisclosureSEC source: 0001524472-26-000002 · form4.xml · nonDerivative · entry 1 Aulick Rodney · CIK 0001720147 · EVP & President, WSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,545 F1 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on December 9, 2022 under the Amended and Restated Evoqua Water Technologies Corp. 2017 Equity Incentive Plan that were converted to Xylem restricted stock units in connection with the Merger on May 24, 2023 F2 · balance_after: Includes additional shares due to dividend reinvestment. Read SEC document |
| December 15, 2025 Filed Dec 15, 2025 21:25 UTC | Xylem Inc. XYL · Entity 430 | Tax withholdingCommon Stock | 1,840 | $138.25 | $254,380.00 |
DisclosureSEC source: 0001524472-25-000054 · form4.xml · nonDerivative · entry 1 Aulick Rodney · CIK 0001720147 · EVP & President, WSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,826 F1 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on December 9, 2022 (1,840) under the Amended and Restated Evoqua Water Technologies Corp. 2017 Equity Incentive Plan that were converted to Xylem restricted stock units in connection with the Merger on May 24, 2023 Read SEC document |
| May 27, 2025 Filed May 27, 2025 21:01 UTC | Xylem Inc. XYL · Entity 430 | Tax withholdingCommon Stock | 1,665 | $126.24 | $210,189.60 |
DisclosureSEC source: 0001562180-25-004206 · primarydocument.xml · nonDerivative · entry 1 Aulick Rodney · CIK 0001720147 · SVP & President, WSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,304 F1 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on May 24, 2023, under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). F2 · balance_after: Includes additional shares due to dividend reinvestment. Read SEC document |
| March 05, 2025 Filed Mar 6, 2025 21:13 UTC | Xylem Inc. XYL · Entity 430 | GrantNon-Qualified Stock Options (Right to buy) · Derivative | 5,751 | $129.67 Strike: $129.67 | $745,732.17 |
DisclosureSEC source: 0001562180-25-002151 · primarydocument.xml · derivative · entry 2 Aulick Rodney · CIK 0001720147 · SVP & President, WSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,751 Underlying: Common Stock · 5,751 shares Expires 2035-03-05 F2 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 5, 2026, March 5, 2027 and March 5, 2028. Read SEC document |
| March 05, 2025 Filed Mar 6, 2025 21:13 UTC | Xylem Inc. XYL · Entity 430 | GrantCommon Stock | 1,639 | $129.67 | $212,529.13 |
DisclosureSEC source: 0001562180-25-002151 · primarydocument.xml · nonDerivative · entry 1 Aulick Rodney · CIK 0001720147 · SVP & President, WSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,774 F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 5, 2026, March 5, 2027 and March 5, 2028. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:12 UTC | Xylem Inc. XYL · Entity 430 | Tax withholdingCommon Stock | 166 | $129.78 | $21,543.48 |
DisclosureSEC source: 0001562180-25-001957 · primarydocument.xml · nonDerivative · entry 1 Aulick Rodney · CIK 0001720147 · SVP & President, WSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,135 F1 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2024 (166) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). F2 · balance_after: Includes additional shares due to dividend reinvestment. Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 21:16 UTC | Xylem Inc. XYL · Entity 430 | Tax withholdingCommon Stock | 1,316 | $116.02 | $152,682.32 |
DisclosureSEC source: 0001562180-25-000106 · primarydocument.xml · nonDerivative · entry 1 Aulick Rodney · CIK 0001720147 · SVP & President, WSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,301 F1 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of: 1) restricted stock units granted on February 16, 2021 under the Evoqua Water Technologies 2017 Equity Plan (Evoqua Plan) that were converted to Xylem restricted stock units in connection with the Merger on May 24, 2023; 2) restricted stock units granted on December 31, 2021 under the Evoqua Plan that were converted to Xylem restricted stock units in connection with the Merger on May 24, 2023; and 3) restricted stock units granted on December 9, 2022 under the Evoqua Plan that were converted to Xylem restricted stock units in connection with the Merger on May 24, 2023 F2 · balance_after: Includes additional shares due to dividend reinvestment. Read SEC document |
| December 16, 2024 Filed Dec 17, 2024 21:24 UTC | Xylem Inc. XYL · Entity 430 | Tax withholdingCommon Stock | 1,558 | $120.60 | $187,894.80 |
DisclosureSEC source: 0001562180-24-008448 · primarydocument.xml · nonDerivative · entry 1 Aulick Rodney · CIK 0001720147 · SVP & President, WSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,448 F1 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance share units granted on December 31, 2021 under the Evoqua Water Technologies 2017 Equity Plan (Evoqua Plan) that were converted to Xylem restricted stock units in connection with the Merger on May 24, 2023. F2 · balance_after: Includes additional shares due to dividend reinvestment. Read SEC document |
| June 05, 2024 Filed Jun 6, 2024 20:32 UTC | Xylem Inc. XYL · Entity 430 | Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 21,800 | $0.00 Strike: $49.23 | $0.00 |
DisclosureSEC source: 0001562180-24-004747 · primarydocument.xml · derivative · entry 3 Aulick Rodney · CIK 0001720147 · SVP & President, WSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,800 Underlying: Common Stock · 21,800 shares Expires 2030-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The February 14, 2020 option grant vested one fourth on January 1, 2021, January 1, 2022, January 1, 2023, and January 1, 2024. Read SEC document |
| June 05, 2024 Filed Jun 6, 2024 20:32 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 21,800 | $139.01 | $3,030,387.48 |
DisclosureSEC source: 0001562180-24-004747 · primarydocument.xml · nonDerivative · entry 2 Aulick Rodney · CIK 0001720147 · SVP & President, WSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,287 F1 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 21,800 Shares were executed at a range of prices from $139.00 to $139.07. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
| June 05, 2024 Filed Jun 6, 2024 20:32 UTC | Xylem Inc. XYL · Entity 430 | Exercise / conversionCommon Stock | 21,800 | $49.23 | $1,073,214.00 |
DisclosureSEC source: 0001562180-24-004747 · primarydocument.xml · nonDerivative · entry 1 Aulick Rodney · CIK 0001720147 · SVP & President, WSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98,087 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2024 Filed May 28, 2024 20:25 UTC | Xylem Inc. XYL · Entity 430 | Tax withholdingCommon Stock | 1,609 | $144.25 | $232,098.25 |
DisclosureSEC source: 0001562180-24-004469 · primarydocument.xml · nonDerivative · entry 1 Aulick Rodney · CIK 0001720147 · SVP & President, WSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,287 F1 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 24, 2023, under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). Read SEC document |
| May 18, 2024 Filed May 21, 2024 20:18 UTC | Xylem Inc. XYL · Entity 430 | Tax withholdingCommon Stock | 4,268 | $143.32 | $611,689.76 |
DisclosureSEC source: 0001562180-24-004263 · primarydocument.xml · nonDerivative · entry 1 Aulick Rodney · CIK 0001720147 · SVP & President, WSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,896 F1 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of: 1) restricted stock units granted on May 18, 2021 under the Evoqua Water Technologies 2017 Equity Plan (Evoqua Plan) that were converted to Xylem restricted stock units in connection with the Merger on May 24, 2023; and 2) performance share units granted on May 18, 2021 under the Evoqua Plan that were converted to Xylem restricted stock units in connection with the Merger on May 24, 2023. F2 · balance_after: Includes additional shares due to dividend reinvestment. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:06 UTC | Xylem Inc. XYL · Entity 430 | GrantStock Options (Right to buy) · Derivative | 5,619 | $127.94 Strike: $127.94 | $718,894.86 |
DisclosureSEC source: 0001562180-24-002295 · primarydocument.xml · derivative · entry 2 Aulick Rodney · CIK 0001720147 · SVP & President, WSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,619 Underlying: Common Stock · 5,619 shares Expires 2034-03-01 F2 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2025, March 1, 2026 and March 1, 2027. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:06 UTC | Xylem Inc. XYL · Entity 430 | GrantCommon Stock | 1,661 | $127.94 | $212,508.34 |
DisclosureSEC source: 0001562180-24-002295 · primarydocument.xml · nonDerivative · entry 1 Aulick Rodney · CIK 0001720147 · SVP & President, WSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,156 F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 1, 2025, March 1, 2026 and March 1, 2027. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:36 UTC | Xylem Inc. XYL · Entity 430 | Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 23,870 | $0.00 Strike: $43.50 | $0.00 |
DisclosureSEC source: 0001562180-24-001390 · primarydocument.xml · derivative · entry 3 Aulick Rodney · CIK 0001720147 · SVP & President, WSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,870 Underlying: Common Stock · 23,870 shares Expires 2028-04-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The April 2, 2018 option grant vested one fourth on January 1, 2019, January 1, 2020, January 1, 2021, and January 1, 2022. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:36 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 23,870 | $122.55 | $2,925,158.70 |
DisclosureSEC source: 0001562180-24-001390 · primarydocument.xml · nonDerivative · entry 2 Aulick Rodney · CIK 0001720147 · SVP & President, WSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,495 F1 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 23,870 Shares were executed at a range of prices from $122.45 to $123.4499. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:36 UTC | Xylem Inc. XYL · Entity 430 | Exercise / conversionCommon Stock | 23,870 | $43.50 | $1,038,345.00 |
DisclosureSEC source: 0001562180-24-001390 · primarydocument.xml · nonDerivative · entry 1 Aulick Rodney · CIK 0001720147 · SVP & President, WSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,365 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 21:18 UTC | Xylem Inc. XYL · Entity 430 | Tax withholdingCommon Stock | 524 | $114.36 | $59,924.64 |
DisclosureSEC source: 0001562180-24-000096 · primarydocument.xml · nonDerivative · entry 4 Aulick Rodney · CIK 0001720147 · SVP & President, WSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,495 F4 · shares: Reflects units withheld to pay the tax liability incident to the vesting of restricted stock units granted on February 16, 2021 under the Evoqua Water Technologies 2017 Equity Plan. F5 · balance_after: Includes additional shares of earned but unvested PSUs which were converted to unvested RSUs at the time of acquisition on May 24, 2023. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 21:18 UTC | Xylem Inc. XYL · Entity 430 | Tax withholdingCommon Stock | 340 | $114.36 | $38,882.40 |
DisclosureSEC source: 0001562180-24-000096 · primarydocument.xml · nonDerivative · entry 3 Aulick Rodney · CIK 0001720147 · SVP & President, WSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,967 F3 · shares: Reflects units withheld to pay the tax liability incident to the vesting of restricted stock units granted on December 31, 2021 under the Evoqua Water Technologies 2017 Equity Plan. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 21:18 UTC | Xylem Inc. XYL · Entity 430 | Tax withholdingCommon Stock | 396 | $114.36 | $45,286.56 |
DisclosureSEC source: 0001562180-24-000096 · primarydocument.xml · nonDerivative · entry 2 Aulick Rodney · CIK 0001720147 · SVP & President, WSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,307 F2 · shares: Reflects units withheld to pay the tax liability incident to the vesting of restricted stock units granted on February 14, 2020 under the Evoqua Water Technologies 2017 Equity Plan. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 21:18 UTC | Xylem Inc. XYL · Entity 430 | Tax withholdingCommon Stock | 400 | $114.36 | $45,744.00 |
DisclosureSEC source: 0001562180-24-000096 · primarydocument.xml · nonDerivative · entry 1 Aulick Rodney · CIK 0001720147 · SVP & President, WSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,703 F1 · shares: Reflects units withheld to pay the tax liability incident to the vesting of restricted stock units granted on December 9, 2022 under the Evoqua Water Technologies 2017 Equity Plan. Read SEC document |
| May 24, 2023 Filed May 26, 2023 21:34 UTC | Xylem Inc. XYL · Entity 430 | GrantCommon Stock | 62,682 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-004540 · primarydocument.xml · nonDerivative · entry 2 Aulick Rodney · CIK 0001720147 · SVP & President, IS&S 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,103 F2 · shares: Received in exchange for 130,589 shares of Evoqua common stock in connection with the Merger. On May 24, 2023, the effective date of the Merger, the closing price of Evoqua's common stock was $49.88 per share, and the closing price of Xylem Inc.'s common stock was $101.06 per share. Read SEC document |
| May 24, 2023 Filed May 26, 2023 21:34 UTC | Xylem Inc. XYL · Entity 430 | GrantCommon Stock | 7,421 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-004540 · primarydocument.xml · nonDerivative · entry 1 Aulick Rodney · CIK 0001720147 · SVP & President, IS&S 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,421 F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) and sub-pool of shares from the Evoqua Water Technologies 2017 Equity Plan assumed by Xylem Inc. as part of the merger of Xylem Inc. and Evoqua Water Technologies Corp. ("Evoqua") on May 24, 2023 (the "Merger"), that are scheduled to vest in two equal parts on May 24, 2024 and on May 24, 2025. Read SEC document |
| May 24, 2023 Filed May 26, 2023 16:26 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | Disposition to issuerStock Option (Right to Buy) · Derivative | 36,200 | Not disclosed Strike: $24.76 | Not disclosed |
DisclosureSEC source: 0001604643-23-000081 · wf-form4_168513276742715.xml · derivative · entry 6 Aulick Rodney · CIK 0001720147 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36,200 shares Expires 2031-02-16 F5 · price: Pursuant to the merger agreement, the Xylem option exercise price is equal to the issuer option exercise price divided by 0.48, rounded up to the nearest whole cent. F4 · derivative.exercise_date: Pursuant to the merger agreement, outstanding options for issuer common stock were assumed by Xylem and converted into options for Xylem common shares, in an amount equal to the number of shares of issuer common stock underlying the options multiplied by 0.48, rounded down to the nearest whole share. F7 · derivative.exercise_date: This option vests in four equal installments starting on Feb. 16, 2022. Read SEC document |
| May 24, 2023 Filed May 26, 2023 16:26 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | Disposition to issuerStock Option (Right to Buy) · Derivative | 45,417 | Not disclosed Strike: $23.63 | Not disclosed |
DisclosureSEC source: 0001604643-23-000081 · wf-form4_168513276742715.xml · derivative · entry 5 Aulick Rodney · CIK 0001720147 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 45,417 shares Expires 2030-02-14 F5 · price: Pursuant to the merger agreement, the Xylem option exercise price is equal to the issuer option exercise price divided by 0.48, rounded up to the nearest whole cent. F4 · derivative.exercise_date: Pursuant to the merger agreement, outstanding options for issuer common stock were assumed by Xylem and converted into options for Xylem common shares, in an amount equal to the number of shares of issuer common stock underlying the options multiplied by 0.48, rounded down to the nearest whole share. F6 · derivative.exercise_date: This option vests in four equal annual installments starting on Jan. 1, 2021. Read SEC document |
| May 24, 2023 Filed May 26, 2023 16:26 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | Disposition to issuerStock Option (Right to Buy) · Derivative | 19,280 | Not disclosed Strike: $12.67 | Not disclosed |
DisclosureSEC source: 0001604643-23-000081 · wf-form4_168513276742715.xml · derivative · entry 4 Aulick Rodney · CIK 0001720147 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,280 shares Expires 2029-02-14 F5 · price: Pursuant to the merger agreement, the Xylem option exercise price is equal to the issuer option exercise price divided by 0.48, rounded up to the nearest whole cent. F3 · derivative.exercise_date: This option is fully vested. F4 · derivative.exercise_date: Pursuant to the merger agreement, outstanding options for issuer common stock were assumed by Xylem and converted into options for Xylem common shares, in an amount equal to the number of shares of issuer common stock underlying the options multiplied by 0.48, rounded down to the nearest whole share. Read SEC document |
| May 24, 2023 Filed May 26, 2023 16:26 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | Disposition to issuerStock Option (Right to Buy) · Derivative | 49,730 | Not disclosed Strike: $20.88 | Not disclosed |
DisclosureSEC source: 0001604643-23-000081 · wf-form4_168513276742715.xml · derivative · entry 3 Aulick Rodney · CIK 0001720147 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 49,730 shares Expires 2028-04-02 F5 · price: Pursuant to the merger agreement, the Xylem option exercise price is equal to the issuer option exercise price divided by 0.48, rounded up to the nearest whole cent. F3 · derivative.exercise_date: This option is fully vested. F4 · derivative.exercise_date: Pursuant to the merger agreement, outstanding options for issuer common stock were assumed by Xylem and converted into options for Xylem common shares, in an amount equal to the number of shares of issuer common stock underlying the options multiplied by 0.48, rounded down to the nearest whole share. Read SEC document |
| May 24, 2023 Filed May 26, 2023 16:26 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | Disposition to issuerCommon Stock | 155,703 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001604643-23-000081 · wf-form4_168513276742715.xml · nonDerivative · entry 2 Aulick Rodney · CIK 0001720147 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F2 · price: Disposed of pursuant to the merger agreement. Upon effectiveness of the merger, (i) each issued and outstanding share of issuer common stock was exchanged for 0.48 Xylem common shares, with cash paid in lieu of fractional shares, and (ii) unvested restricted stock units ("RSUs") and PSUs (at target award level) were converted into RSUs relating to Xylem common shares, by multiplying the number of shares of issuer common stock underlying the award and 0.48, rounded down to the nearest whole share. Read SEC document |
| May 24, 2023 Filed May 26, 2023 16:26 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | GrantCommon Stock | 25,114 | $0.00 | $0.00 |
DisclosureSEC source: 0001604643-23-000081 · wf-form4_168513276742715.xml · nonDerivative · entry 1 Aulick Rodney · CIK 0001720147 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,703 F1 · shares: Represents performance share units ("PSUs") that became earned (at target award level) pursuant to the merger agreement among Xylem Inc., Fore Merger Sub, Inc. and the issuer, dated as of Jan. 22, 2023, upon effectiveness of the merger on May 24, 2023. Read SEC document |
| May 20, 2023 Filed May 22, 2023 17:51 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | GrantCommon Stock | 4,394 | $0.00 | $0.00 |
DisclosureSEC source: 0001604643-23-000068 · wf-form4_168479225182797.xml · nonDerivative · entry 2 Aulick Rodney · CIK 0001720147 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,589 F1 · shares: Represents performance share units ("PSUs") that were earned pursuant to the terms of the PSU award granted on May 18, 2021, upon certification by the Compensation Committee of the performance results for the period ended May 18, 2023. F2 · balance_after: The amount of these securities includes an aggregate of 35,023 unvested restricted stock units and earned performance share units that are not yet settled, in each case, in respect of the issuer's common stock. Read SEC document |
| May 18, 2023 Filed May 22, 2023 17:51 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | Tax withholdingCommon Stock | 806 | $49.09 | $39,566.54 |
DisclosureSEC source: 0001604643-23-000068 · wf-form4_168479225182797.xml · nonDerivative · entry 1 Aulick Rodney · CIK 0001720147 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,195 Read SEC document |
| May 08, 2023 Filed May 10, 2023 17:42 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | Exercise / conversionStock Option (Right to Buy) · Derivative | 200 | $0.00 Strike: $12.67 | $0.00 |
DisclosureSEC source: 0001604643-23-000050 · wf-form4_168375496701098.xml · derivative · entry 3 Aulick Rodney · CIK 0001720147 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,280 Underlying: Common Stock · 200 shares Expires 2029-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2022. F4 · derivative.exercise_date: This option is fully vested. Read SEC document |
| May 08, 2023 Filed May 10, 2023 17:42 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | SaleCommon Stock | 200 | $52.10 | $10,420.00 |
DisclosureSEC source: 0001604643-23-000050 · wf-form4_168375496701098.xml · nonDerivative · entry 2 Aulick Rodney · CIK 0001720147 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,001 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.01 to $52.19, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: The amount of these securities includes an aggregate of 33,558 unvested restricted stock units and earned performance share units that are not yet settled, in each case, in respect of the issuer's common stock. Read SEC document |
| May 08, 2023 Filed May 10, 2023 17:42 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | Exercise / conversionCommon Stock | 200 | $12.67 | $2,534.00 |
DisclosureSEC source: 0001604643-23-000050 · wf-form4_168375496701098.xml · nonDerivative · entry 1 Aulick Rodney · CIK 0001720147 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,201 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2022. F2 · balance_after: The amount of these securities includes an aggregate of 33,558 unvested restricted stock units and earned performance share units that are not yet settled, in each case, in respect of the issuer's common stock. Read SEC document |
| February 07, 2023 Filed Feb 9, 2023 18:16 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,494 | $0.00 Strike: $12.67 | $0.00 |
DisclosureSEC source: 0001604643-23-000038 · wf-form4_167598458558109.xml · derivative · entry 4 Aulick Rodney · CIK 0001720147 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,480 Underlying: Common Stock · 6,494 shares Expires 2029-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2022. F5 · derivative.exercise_date: This option is fully vested. Read SEC document |
| February 07, 2023 Filed Feb 9, 2023 18:16 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | SaleCommon Stock | 200 | $51.25 | $10,250.00 |
DisclosureSEC source: 0001604643-23-000038 · wf-form4_167598458558109.xml · nonDerivative · entry 3 Aulick Rodney · CIK 0001720147 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,001 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.1500 to $51.3500, inclusive. F2 · balance_after: The amount of these securities includes 33,558 unvested restricted stock units and earned performance share units that are not yet settled, in each case, in respect of the issuer's common stock. Read SEC document |
| February 07, 2023 Filed Feb 9, 2023 18:16 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | SaleCommon Stock | 6,294 | $50.33 | $316,746.81 |
DisclosureSEC source: 0001604643-23-000038 · wf-form4_167598458558109.xml · nonDerivative · entry 2 Aulick Rodney · CIK 0001720147 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,201 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.0000 to $50.7100, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3 and 4 to this Form 4. F2 · balance_after: The amount of these securities includes 33,558 unvested restricted stock units and earned performance share units that are not yet settled, in each case, in respect of the issuer's common stock. Read SEC document |
| February 07, 2023 Filed Feb 9, 2023 18:16 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | Exercise / conversionCommon Stock | 6,494 | $12.67 | $82,278.98 |
DisclosureSEC source: 0001604643-23-000038 · wf-form4_167598458558109.xml · nonDerivative · entry 1 Aulick Rodney · CIK 0001720147 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,495 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2022. F2 · balance_after: The amount of these securities includes 33,558 unvested restricted stock units and earned performance share units that are not yet settled, in each case, in respect of the issuer's common stock. Read SEC document |
| January 01, 2023 Filed Jan 4, 2023 18:06 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | Tax withholdingCommon Stock | 3,678 | $39.60 | $145,648.80 |
DisclosureSEC source: 0001604643-23-000011 · wf-form4_167287356499047.xml · nonDerivative · entry 1 Aulick Rodney · CIK 0001720147 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,001 F1 · balance_after: The amount of these securities includes an aggregate of 33,558 unvested restricted stock units and earned performance share units that are not yet settled, in each case, in respect of the issuer's common stock. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 16:47 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | GrantCommon Stock | 8,840 | $0.00 | $0.00 |
DisclosureSEC source: 0001604643-22-000138 · wf-form4_167096803248333.xml · nonDerivative · entry 1 Aulick Rodney · CIK 0001720147 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,679 F1 · kind: The reported transaction is an award of restricted stock units in respect of the issuer's common stock. Subject to the reporting person's continued employment with the issuer through the applicable vesting date, these restricted stock units are scheduled to vest in equal installments on each of January 1, 2024, January 1, 2025, and January 1, 2026, and settle within 30 days of the applicable vesting date. F2 · balance_after: The amount of these securities includes an aggregate of 46,191 unvested restricted stock units and earned performance share units that are not yet settled, in each case, in respect of the issuer's common stock. Read SEC document |
| May 21, 2022 Filed May 24, 2022 17:18 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | GrantCommon Stock | 4,394 | $0.00 | $0.00 |
DisclosureSEC source: 0001604643-22-000109 · wf-form4_165342712370087.xml · nonDerivative · entry 1 Aulick Rodney · CIK 0001720147 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,839 F1 · shares: Represents the number of performance share units earned under the performance share unit award granted on May 18, 2021, upon certification by the Compensation Committee of the issuer's performance results for the one-year performance period ended May 18, 2022. The earned performance share units will settle at the end of the final performance period under the award on May 18, 2024, subject to the reporting person's continued employment with the issuer. F2 · balance_after: The amount of these securities includes an aggregate of 37,351 unvested restricted stock units and earned performance share units that are not yet settled, in each case, in respect of the issuer's common stock. Read SEC document |
| May 18, 2022 Filed May 20, 2022 17:10 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | Tax withholdingCommon Stock | 805 | $36.35 | $29,261.75 |
DisclosureSEC source: 0001604643-22-000093 · wf-form4_165308099108594.xml · nonDerivative · entry 1 Aulick Rodney · CIK 0001720147 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,445 F1 · balance_after: The amount of these securities includes 32,957 unvested restricted stock units in respect of the issuer's common stock. Read SEC document |
| February 16, 2022 Filed Feb 17, 2022 17:39 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | Tax withholdingCommon Stock | 900 | $43.98 | $39,582.00 |
DisclosureSEC source: 0001604643-22-000040 · wf-form4_164513754850421.xml · nonDerivative · entry 1 Aulick Rodney · CIK 0001720147 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,250 F1 · balance_after: The amount of these securities includes 35,886 unvested restricted stock units in respect of the issuer's common stock. Read SEC document |
| January 01, 2022 Filed Jan 4, 2022 16:54 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | Tax withholdingCommon Stock | 2,037 | $46.75 | $95,229.75 |
DisclosureSEC source: 0001604643-22-000018 · wf-form4_164133326507151.xml · nonDerivative · entry 2 Aulick Rodney · CIK 0001720147 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,150 F2 · balance_after: The amount of these securities includes 39,167 unvested restricted stock units in respect of the issuer's common stock. Read SEC document |
| December 31, 2021 Filed Jan 4, 2022 16:54 UTC | Evoqua Water Technologies Corp. AQUA · Entity 113037 | GrantCommon Stock | 7,487 | $0.00 | $0.00 |
DisclosureSEC source: 0001604643-22-000018 · wf-form4_164133326507151.xml · nonDerivative · entry 1 Aulick Rodney · CIK 0001720147 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,187 F1 · kind: The reported transaction is an award of restricted stock units in respect of the issuer's common stock. Subject to the reporting person's continued employment with the issuer through the applicable vesting date, these restricted stock units are scheduled to vest in equal installments on each of January 1, 2023, January 1, 2024, and January 1, 2025, and settle within 30 days of the applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.